** New Advocates’ Primer on HPTN 083 and Webinar This Thursday
------------------------------------------------------------
July 15, 2020

Dear Advocates,

At a time when access, health justice and equity are uppermost for us all, AVAC is pleased to offer a new advocates’ guide to long-acting injectable PrEP, a new prevention strategy that’s shown benefit in some populations and generated a lot of buzz recently.

Want to know what’s known and unknown, who should do what, and what you can do? Click here to read Understanding the Results of HPTN 083: avac.org/resource/advocates-primer-long-acting-injectable-cabotegravir-prep.

We’ve also created a webpage of resources for advocates seeking to learn more (avac.org/long-acting-injectable-cabotegravir) —click thru to listen to conversations with HPTN 083 and 084 researchers at the AIDS 2020 Research Literacy Networking Zone, learn more about the history of these trials of long-acting cabotegravir (CAB-LA), and more.

Also, save the date for a webinar, this Thursday, July 16, hosted by the HPTN where you can hear the primary results of HPTN 083 and ask all your burning questions! The call is at 10:30am EDT (visit www.worldtimebuddy.com for your local time zone) and dial-in information is here: [link removed]

In the coming months, we will be convening with prevention research advocates to talk about critical next steps—for CAB-LA and for prevention generally. At AVAC, we will be working to ensure that development and introduction of new PrEP strategies expands equitable access to existing daily oral PrEP, with multi-month prescriptions and self-testing where feasible, to support continued use in COVID-19 contexts. We need your help to advance primary prevention and research agendas that leave no one behind. Join us!

Onwards,
AVAC

============================================================
Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe

Contact Us T: +1 212 796 6423
E: ** [email protected]
W: ** www.avac.org
** www.twitter.com/hivpxresearch
** www.facebook.com/hivpxresearch
** www.youtube.com/hivpxresearch
==============================================

Unsubscribe [email protected] from this list:
[link removed]